[IP in Korea] 'Excessive regulations act as disincentive in pharma patent sector'

[IP in Korea] 'Excessive regulations act as disincentive in pharma patent sector'

The Korea Herald is publishing a series of interviews on experts in the intellectual property sector. This is the 13th installment. — Ed. Due to its active trade relations with leading Western nations, South Korea has long been a frontrunner in introducing patent protection measures in various sectors, including the pharmaceuticals industry. While such early […]

4 Huge Pharma Deals in 4 Months Is Just the Beginning

4 Huge Pharma Deals in 4 Months Is Just the Beginning

I’m still waiting for the trees in my yard to sprout leaves, but we’ve already seen half-a-dozen drugmaker deals worth around $100 billion in total this year. Despite a slew of mergers and acquisitions (M&A) over the past several months, there are still some cash-laden big biotechs and pharmaceutical companies eager to bulk up their […]

BRIEF-Zhongzhu Healthcare To Buy Stakes In Pharma And Hospital Firms

BRIEF-Zhongzhu Healthcare To Buy Stakes In Pharma And Hospital Firms

April 28 (Reuters) – Zhongzhu Healthcare Holding Co Ltd : * SAYS IT PLANS TO BUY 74.5 PERCENT STAKE IN PHARMA FIRM FOR ABOUT 1.8-2.0 BILLION YUAN ($284.25-$315.83 million) VIA CASH * SAYS IT PLANS TO BUY 100 PERCENT STAKE IN HOSPITAL FIRM FOR ABOUT 1.2 BILLION YUAN VIA CASH Source text in Chinese: bit.ly/2r1deB1 […]

Pharma distributors group addresses potential lawsuit

Pharma distributors group addresses potential lawsuit

OSSIPEE — As Carroll County mulls suing Big Pharma over costs associated with the opioid crisis, a national trade association has suggested that a lawsuit isn’t the best way to address the problem. The idea of joining a lawsuit was sparked when Strafford invited Carroll and other New Hampshire counties to participate in a class […]

UK pharma in need of a tonic

UK pharma in need of a tonic

It’s tough to be a British investor with a penchant for big pharma. Since Hikma (HIK) took a dive in 2016, there are just three drugs companies left in the FTSE 100 and none of them is giving much cause for celebration. GlaxoSmithKline (GSK) and Shire(SHP) have both underperformed the benchmark in the last 12 months, […]

AcelRx Pharma (ACRX) Receives Positive CHMP Opinion for DZUVEO for Management of Pain

AcelRx Pharma (ACRX) Receives Positive CHMP Opinion for DZUVEO for Management of Pain

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here. AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx or the Company), a specialty pharmaceutical company focused on innovative therapies for use in medically supervised settings, today announced that the Committee for Medicinal Products for Human Use […]